INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co. of Class Action Lawsuit and Upcoming Deadlines - OGN — Neutral
OGN Accesswire — June 13, 2025NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Organon & Co. ("Organon" or the "Company") (NYSE:OGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
CrowdStrike's Renewed Growth Opportunity Has Been Overbought — Positive
CRWD Seeking Alpha — June 13, 2025CrowdStrike's recent rally has occurred overly fast and furious, since its robust ARR and multi-year backlog growth have yet to be translated to its bottom-lines. With the stock trading at notable premiums compared to the historical trends and its cybersecurity peers, we maintain our belief that there is a minimal margin of safety here. Metrics are also pointing to CRWD's seemingly overbought positions, with the normalization in market sentiments potentially triggering double-digit corrections.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UroGen Pharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - URGN — Neutral
URGN Accesswire — June 13, 2025NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against UroGen Pharma Ltd. ("UroGen" or the "Company") (NASDAQ:URGN).
Johnson & Johnson's dual-targeting CAR T-cell therapy shows encouraging first results in large B-cell lymphoma — Neutral
JNJ PRNewsWire — June 13, 2025Phase 1b study suggests a promising safety profile and highlights the potential of a novel dual-targeting CD19/CD20 CAR T in patients with relapsed or refractory disease 75-80% complete response rate among evaluable patients at the recommended Phase 2 dose MILAN , June 13, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today the first clinical data from an ongoing Phase 1b study for JNJ-90014496 (JNJ-4496), an investigational dual-targeting anti-CD19/CD20 bispecific autologous chimeric antigen receptor (CAR) T-cell therapy, being studied in patients with relapsed or refractory large B-cell lymphoma (R/R LBCL) who have not been previously treated with CAR T-cell …
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV — Neutral
ELV GlobeNewsWire — June 13, 2025NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., June 14, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline.
GDIT Awarded Mission Enhancing Enterprise Contract to Support Special Operations Forces — Neutral
GD PRNewsWire — June 13, 2025Company will leverage AI, cloud and cyber capabilities to enhance operational effectiveness FALLS CHURCH, Va. , June 13, 2025 /PRNewswire/ -- General Dynamics Information Technology (GDIT), a business unit of General Dynamics (NYSE:GD), announced today that it was awarded a foundational Information Technology Enterprise contract to support components of the U.S. Special Operations Command (SOCOM).
Did You Lose Money on UroGen Pharma Ltd. (URGN)? Levi & Korsinsky Urges Investors to Act Before July 28, 2025 — Neutral
URGN Accesswire — June 13, 2025NEW YORK, NY / ACCESS Newswire / June 13, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/urogen-pharma-ltd-lawsuit-submission-form?prid=153004&wire=1&utm_campaign=28 or contact Joseph E.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quipt Home Medical Corp. - QIPT — Neutral
QIPT Accesswire — June 13, 2025NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Compass Diversified (CODI) Faces Crisis as Lugano Scandal Forces Downgrade, Investor Lawsuit – Hagens Berman — Neutral
CODI GlobeNewsWire — June 13, 2025SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- Compass Diversified's (NYSE: CODI) tumultuous spring continued as Jefferies analysts recently downgraded the company's stock amid a sweeping securities class action lawsuit filed by investors, both moves stemming from a widening accounting scandal at its Lugano subsidiary. The dual blows—Wall Street's loss of confidence and mounting legal challenges—have sent Compass's shares into a tailspin, erasing over 70% of the company's market value over the past three months and casting a pall over the once high-flying holding firm.
Speed of oil's move due to fears about spare capacity, says Sankey Research's Paul Sankey — Negative
BNO DBO GUSH IEO OIH OIL PXJ UCO USO XOP CNBC Television — June 13, 2025Paul Sankey, Sankey Research president and lead analyst, joins 'Squawk on the Street' to discuss what the Iran-Israel conflict will mean for energy markets.
Stonegate Updates Coverage on Hooker Furniture Corporation (HOFT) Q1 FY26 — Neutral
HOFT Newsfile Corp — June 13, 2025Dallas, Texas--(Newsfile Corp. - June 13, 2025) - Hooker Furniture Corporation (NASDAQ: HOFT): Stonegate Capital Partners updates their coverage on Hooker Furniture Corporation (NASDAQ: HOFT). HOFT reported revenue, operating income, and adj EPS of $85.3M, ($3.6)M, and ($0.29), respectively.
Here's Why Shake Shack (SHAK) is a Strong Momentum Stock — Positive
SHAK Zacks Investment Research — June 13, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Scotts Miracle-Gro (SMG) is a Strong Momentum Stock — Positive
SMG Zacks Investment Research — June 13, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Royal Caribbean (RCL) is a Strong Momentum Stock — Positive
RCL Zacks Investment Research — June 13, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cardinal Health (CAH) is a Top-Ranked Momentum Stock: Should You Buy? — Positive
CAH Zacks Investment Research — June 13, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why CF Industries (CF) is a Strong Momentum Stock — Positive
CF Zacks Investment Research — June 13, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Euronet Worldwide (EEFT) is a Top Momentum Stock for the Long-Term — Positive
EEFT Zacks Investment Research — June 13, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Manulife Financial (MFC) is a Top Momentum Stock for the Long-Term — Positive
MFC Zacks Investment Research — June 13, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Valmont Industries (VMI) is a Top Momentum Stock for the Long-Term — Positive
VMI Zacks Investment Research — June 13, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Jones Lang LaSalle (JLL) is a Strong Momentum Stock — Positive
JLL Zacks Investment Research — June 13, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
